Developer docs
API playgroundTry for free, no card

Search company profiles

Promega

Full company profile

uuid00042md

Namestring
Promega
Legal namestring
Promega Corporation
Websiteurl
promega.com
Company typeenum
Private
Founded yearint
1978
Descriptiontext

Promega Corporation is a privately held life sciences tools company founded in 1978 and headquartered in Madison, Wisconsin, that develops, manufactures, and globally distributes proprietary reagents, assay kits, instruments, and molecular diagnostic products. The company's core technology stack is anchored on its proprietary NanoLuc luciferase platform — a small, extremely bright bioluminescent enzyme — and a family of derived platforms including NanoBRET (for live-cell target engagement measurement), HiBiT (an 11-amino-acid protein tagging system), HaloTag (covalent protein labeling), and LumIt (bioluminescent immunoassays). Hardware products include GloMax Discover multimode microplate readers, Maxwell RSC automated nucleic acid purification systems, the Maxprep liquid handler, Spectrum CE capillary electrophoresis instruments, and Quantus fluorometers, with SiLA2-compliant lab automation integration. The commercial business sells research reagents and consumables, instruments, custom manufacturing services (including lyophilized PCR master mixes and mRNA manufacturing raw materials), molecular diagnostic kits (notably the OncoMate MSI Dx Analysis System, FDA-approved in November 2025 as a companion diagnostic for KEYTRUDA plus LENVIMA, and NMPA-approved in China in February 2026), and forensic DNA analysis products.

Promega serves five primary customer segments — pharmaceutical and biotechnology drug discovery, molecular diagnostics and clinical research, forensic science and human identification, applied sciences/One Health, and academic education — across more than 25 countries through a combination of direct field sales, a global distributor network, a catalog-based e-commerce storefront, and dedicated Technical Services Scientists. The company operates on a quote-based pricing model with account-based catalog pricing, one-time reagent sales, hardware sales, and custom services revenue, and has no disclosed outside funding rounds, suggesting it is founder-owned and self-financed under chairman and CEO William Linton. Recent strategic actions — MilliporeSigma co-development for organoid-based drug screening (October 2025), FDA and NMPA approvals of the OncoMate MSI platform, the TarSeer BRETSA Target Engagement System launch at SLAS 2026 (February 2026), and a NimaGen forensic MPS distribution agreement (April 2026) — signal an active expansion phase into companion diagnostics, 3D cell-culture drug discovery, and next-generation forensic sequencing.

Short descriptiontext

Promega Corporation is a privately held Madison, Wisconsin life sciences company manufacturing proprietary bioluminescent reagents, NanoBRET and HaloTag assay platforms, instruments, and FDA/NMPA-approved molecular diagnostic kits for pharmaceutical, academic, forensic, and clinical research customers worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersMadison, United States
HQ citystring
Madison
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life sciences reagents, molecular biology assays, bioluminescence technology, forensic DNA analysis, molecular diagnostics kits
Industry4 codes
PRIMARYHLAAAIAI
Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing
SECONDARYHLAGADAM
Forensic & Anti-Counterfeit Testing (Product Integrity)
NAICS code3 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Laboratory Analytical Instruments3826
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
Product category
Life Sciences Research Reagents and Instruments
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Research Reagents and Consumables
TypeOne Time License
Description

Sale of biological reagents including luciferase assays, PCR systems, RNA extraction kits, and cell biology reagents for research laboratories

promega.com
2Laboratory Instruments
TypeHardware Sales
Description

Sale of specialized laboratory instruments including GloMax plate readers, Maxwell automated purification systems, and Spectrum CE Systems

promega.com
3Molecular Diagnostics
TypeOne Time License
Description

Sale of diagnostic kits including OncoMate MSI Detection Kit for companion diagnostics in oncology

promega.com
4Custom Manufacturing Services
TypeProfessional Services
Description

Custom manufacturing capabilities including lyophilized PCR master mixes, mRNA manufacturing raw materials, and tailored R&D solutions

promega.com
5Forensic DNA Analysis Products
TypeOne Time License
Description

Kits and instruments for forensic DNA analysis supporting law enforcement and forensic laboratories

promega.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details2 tiers
1Web-based product catalog with account pricing
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Products available through Promega.com with account-based pricing. Technical consultation and custom manufacturing services available through sales contacts.

promega.com
2Email subscription with 20% discount incentive
ModelSubscriptionBilling cadenceMonthly
Notes

Sign up for email communications and receive 20% off next web order. Promotional code cannot be applied to transfection reagents, biochemicals, OncoMate MSI Dx Analysis System, and labware/consumables/custom products.

promega.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 10 records shown
1GloMax
Description

Line of microplate readers and luminometers for luminescence, fluorescence, and absorbance detection

promega.com
+9 more records
Core offering1 text field

Promega Corporation develops and manufactures biological research reagents, assay kits, laboratory instruments, and molecular diagnostic products for life science research, drug discovery, forensic human identification, and clinical diagnostics. Its portfolio centers on proprietary NanoLuc luciferase-based bioluminescence platforms and includes nucleic acid extraction systems, PCR reagents, transfection reagents, plate readers, and companion diagnostic kits such as the OncoMate MSI Detection System.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • TarSeer BRETSA system applied to over 20 target classes
+1 more record
Product overview1 text field

Promega Corporation is a life sciences reagent and instrument company offering a broad portfolio of bioluminescent technologies, assays, instruments, and molecular biology tools. The core technology platform centers on NanoLuc Luciferase and NanoBRET Target Engagement technology, which power products for drug discovery target engagement studies (NanoBRET TE K192 Kinase Selectivity System, TarSeer BRETSA System), cell biology assays, and protein analysis. The product portfolio includes: GoTaq Probe qPCR/RT-qPCR Systems for nucleic acid amplification; ReliaPrep RNA Miniprep and Maxwell RSC automated purification systems for sample preparation; GloMax Discover multimode plate readers and Quantus Fluorometer for detection; FuGENE HD transfection reagents for cellular delivery; QuantiFluor RNA Systems for quantitation; Water-Glo ATP testing for environmental monitoring; and forensic DNA analysis tools including OncoMate MSI Detection Kit and Spectrum CE Systems. Additional technology platforms include HaloTag protein labeling, HiBiT protein tagging, and Lumit bioluminescence immunoassays. The company offers custom manufacturing services including mRNA raw materials and assay development, distributed through global distribution agreements such as NimaGen IDseek MPS kits.

Product and service15 records
1NanoBRET TE K192 Kinase Selectivity System
CategoryDrug Discovery / Target Engagement Assay
Description

Live-cell assay system profiling compound cellular selectivity against 192 human kinases in a single experiment, providing quantitative occupancy data using an addition-only protocol.

2GoTaq Probe qPCR and RT-qPCR Systems
CategoryNucleic Acid Analysis / PCR Reagents
Description

Ready-to-use 2X master mixes for quantitative PCR and RT-qPCR using hydrolysis probe detection, compatible with most real-time PCR instruments and resistant to PCR inhibitors.

3ReliaPrep RNA Miniprep Systems
CategoryNucleic Acid Extraction
Description

Membrane-based RNA purification system for extracting high-quality total RNA from cultured cells and tissue samples with on-column DNase treatment, processing 100 cells to 5 million cells per prep.

4GloMax Discover Microplate Reader
CategoryLaboratory Instrument
Description

Multimode microplate reader with luminescence, fluorescence, UV-visible absorbance, BRET and FRET detection capabilities for 6- to 384-well formats, optimized with Promega assay chemistries and SiLA2-compliant for lab automation integration.

5FuGENE HD Transfection Reagent
CategoryCell Biology Reagent
Description

Non-liposomal transfection reagent for delivering nucleic acids into eukaryotic cells with high efficiency and low toxicity, compatible with serum-containing media and difficult-to-transfect cell lines.

6QuantiFluor RNA System
CategoryRNA Quantitation Reagent
Description

Fluorescent RNA-binding dye system for sensitive quantitation of small amounts of RNA, detecting as little as 100pg RNA with 0.1-500ng per microliter range.

7QuantiFluor RNA Select System
CategoryRNA Quantitation Reagent
Description

Add-and-read fluorescent RNA quantitation system with broad dynamic range (16-1000ng per microliter), ideal for RNA sequencing template inputs with ambient shipping compatibility.

8Water-Glo System
CategoryApplied Sciences / Water Testing
Description

ATP bioluminescence-based microbial water testing kit providing low-level detection of all live microbes in minutes for industrial process, drinking water, wastewater, and environmental monitoring.

9Maxwell RSC simplyRNA Blood Kit
CategoryNucleic Acid Extraction
Description

Automated RNA purification kit for extracting total RNA from 2.5ml fresh whole blood samples using Maxwell RSC Instruments with low elution volume.

10pmirGLO Dual-Luciferase miRNA Target Expression Vector
CategoryLuciferase Reporter / Vector
Description

Reporter vector for quantitatively evaluating microRNA activity by inserting target sites downstream of firefly luciferase gene, with Renilla luciferase normalization.

11Dual-Glo Luciferase Assay System
CategoryLuciferase Reporter Assay
Description

Homogeneous reagent system for consecutive detection of firefly and Renilla luciferase activities in a single sample with 2-hour extended signal half-life, using an add-mix-measure protocol.

12OncoMate MSI Detection Kit
CategoryMolecular Diagnostic / Companion Diagnostic
Description

PCR-based microsatellite instability (MSI) detection assay for identifying MSI-High solid tumor patients as a companion diagnostic for KEYTRUDA immunotherapy.

13TarSeer BRETSA Target Engagement System
CategoryDrug Discovery / Target Engagement Platform
Description

Live-cell target engagement platform that detects ligand-protein interactions in intact cells using bioluminescence resonance energy transfer-based shift assay technology, addressing the gap between biochemical and cellular assays for drug discovery.

14Helix On-Site Stocking Service
CategoryCustom Service / Onsite Inventory Management
Description

Onsite inventory management and stocking service providing convenient access to Promega products directly in laboratories.

15mRNA Manufacturing Raw Materials
CategoryCustom Manufacturing / mRNA Therapeutics
Description

Custom manufacturing services for mRNA therapeutics research including raw materials for LNP and mRNA delivery applications.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-06-01
Description

Promega contributed laboratory instrumentation to support Cal Poly's new Engineering Synthetic Cells course, combining coursework with research as a Course-based Undergraduate Research Experience (C.U.R.E.).

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-01
Description

Distribution agreement for NimaGen's IDseek massively parallel sequencing kit portfolio. Promega distributes more than 20 products across seven product families, including autosomal and Y-chromosomal STR profiling kits, microhaplotype analysis, and mitochondrial DNA sequencing kits through its global distribution network.

3UBC RNA & Formulation Core
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-01
Description

Authorization granted for UBC RNA & Formulation Core to distribute NanoLuc-Encoding mRNA for LNP and mRNA delivery research. Research supply arrangement supporting mRNA therapeutics research.

businesswire.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-01
Description

Collaboration supporting regulatory approval of Promega's OncoMate MSI Detection Kit as companion diagnostic for KEYTRUDA (pembrolizumab). Promega partnered with Merck for China's NMPA approval of the MSI-High diagnostic assay for solid tumor patients.

5MilliporeSigma (Merck KGaA Life Science)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-01
Description

Partnership to co-develop assay technologies capable of tracking cellular activity in real time within organoids. The collaboration aims to advance drug screening and discovery using 3D cell cultures, with plans to integrate Merck's Duolink with Promega's HiBiT technologies for enhanced cellular analysis.

rdworldonline.com
6Merck KGaA (MilliporeSigma)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-01
Description

Strategic partnership announced in October to co-develop organoid drug screening assays. The collaboration leverages Promega's assay technologies with MilliporeSigma's organoid models for more physiologically relevant drug discovery platforms.

genengnews.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

World's largest life sciences tools and diagnostics company, offering reagents, instruments, and molecular diagnostics. Directly comparable across Promega's portfolio, but at vastly greater scale and with broader catalog spanning everything from cell biology to clinical diagnostics.

TypeDirect peer
Description

Public life sciences tools company with overlapping product lines in PCR/qPCR reagents (similar to GoTaq), digital PCR, protein analysis (Western blot), and clinical diagnostics. Closely comparable in scale, business model, and customer base to Promega.

TypeDirect peer
Description

Research reagents and diagnostics company with comparable portfolio in proteins, antibodies, ELISA/immunoassays (similar to Lumit), and cell/gene therapy workflow tools. Direct competitor in research reagents for drug discovery and academic markets.

TypeDirect peer
Description

Molecular diagnostics and sample preparation specialist with overlapping products in nucleic acid extraction (similar to Maxwell), PCR, and companion diagnostics. Identified in the company data as a Promega competitor, with comparable scale and global footprint.

5Merck KGaA / MilliporeSigma
TypeBroad incumbent
Description

Life science tools division of Merck KGaA offering biochemicals, reagents, and instruments. Active Promega partner on organoid drug screening; broad catalog competes across many of Promega's product lines from a position of greater scale.

TypeBroad incumbent
Description

Analytical instruments and life sciences tools company with comparable offerings in PCR/qPCR, nucleic acid analysis, and cell analysis. Broader portfolio spanning chromatography and mass spectrometry, with significantly larger revenue base than Promega.

TypeBroad incumbent
Description

Life sciences and diagnostics company with overlapping reagents, cell-based assays, and molecular diagnostics. Comparable in life sciences applications segment but operates broader analytical instruments portfolio.

TypeDirect peer
Description

Research reagent company specializing in antibodies and immunoassay tools, recently acquired by Danaher. Direct competitor in immunoassay reagents and protein detection — comparable to Promega's Lumit and HaloTag platforms for academic and pharma research customers.

TypeEmerging player
Description

Biotechnology reagent and service company with comparable offerings in gene synthesis, protein production, and cell therapy reagents. Overlaps with Promega's nucleic acid and protein analysis tools, particularly for synthetic biology and cell/gene therapy customers.

TypeEmerging player
Description

Specialty provider of primary cells, cell culture reagents, and cell-based assays with overlapping offerings in cell biology research. Comparable target customer base (academic and pharma researchers) but narrower product portfolio than Promega.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Promega

Life Sciences Research Reagents and Instrumentspromega.com

Promega Corporation is a privately held Madison, Wisconsin life sciences company manufacturing proprietary bioluminescent reagents, NanoBRET and HaloTag assay platforms, instruments, and FDA/NMPA-approved molecular diagnostic kits for pharmaceutical, academic, forensic, and clinical research customers worldwide.

What Promega does

Promega Corporation is a privately held life sciences tools company founded in 1978 and headquartered in Madison, Wisconsin, that develops, manufactures, and globally distributes proprietary reagents, assay kits, instruments, and molecular diagnostic products. The company's core technology stack is anchored on its proprietary NanoLuc luciferase platform — a small, extremely bright bioluminescent enzyme — and a family of derived platforms including NanoBRET (for live-cell target engagement measurement), HiBiT (an 11-amino-acid protein tagging system), HaloTag (covalent protein labeling), and LumIt (bioluminescent immunoassays). Hardware products include GloMax Discover multimode microplate readers, Maxwell RSC automated nucleic acid purification systems, the Maxprep liquid handler, Spectrum CE capillary electrophoresis instruments, and Quantus fluorometers, with SiLA2-compliant lab automation integration. The commercial business sells research reagents and consumables, instruments, custom manufacturing services (including lyophilized PCR master mixes and mRNA manufacturing raw materials), molecular diagnostic kits (notably the OncoMate MSI Dx Analysis System, FDA-approved in November 2025 as a companion diagnostic for KEYTRUDA plus LENVIMA, and NMPA-approved in China in February 2026), and forensic DNA analysis products.

Promega serves five primary customer segments — pharmaceutical and biotechnology drug discovery, molecular diagnostics and clinical research, forensic science and human identification, applied sciences/One Health, and academic education — across more than 25 countries through a combination of direct field sales, a global distributor network, a catalog-based e-commerce storefront, and dedicated Technical Services Scientists. The company operates on a quote-based pricing model with account-based catalog pricing, one-time reagent sales, hardware sales, and custom services revenue, and has no disclosed outside funding rounds, suggesting it is founder-owned and self-financed under chairman and CEO William Linton. Recent strategic actions — MilliporeSigma co-development for organoid-based drug screening (October 2025), FDA and NMPA approvals of the OncoMate MSI platform, the TarSeer BRETSA Target Engagement System launch at SLAS 2026 (February 2026), and a NimaGen forensic MPS distribution agreement (April 2026) — signal an active expansion phase into companion diagnostics, 3D cell-culture drug discovery, and next-generation forensic sequencing.

Promega firmographics

Firmographics
Name
Promega
Legal name
Promega Corporation
Website
https://promega.com
Company type
Private
Founded year
1978
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Promega Corporation is a privately held Madison, Wisconsin life sciences company manufacturing proprietary bioluminescent reagents, NanoBRET and HaloTag assay platforms, instruments, and FDA/NMPA-approved molecular diagnostic kits for pharmaceutical, academic, forensic, and clinical research customers worldwide.
Ownership category
akta.pro rank

Promega industry classification

Industry
Product category
Life Sciences Research Reagents and Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAAIAI
Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing
SECONDARYHLAGADAM
Forensic & Anti-Counterfeit Testing (Product Integrity)

Keywords

  • Life sciences reagents
  • Molecular biology assays
  • Bioluminescence technology
  • Forensic DNA analysis
  • Molecular diagnostics kits

Where Promega is headquartered

Location

Headquarters

HQ city
Madison
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Promega business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Research Reagents and Consumables: Sale of biological reagents including luciferase assays, PCR systems, RNA extraction kits, and cell biology reagents for research laboratories
  2. Laboratory Instruments: Sale of specialized laboratory instruments including GloMax plate readers, Maxwell automated purification systems, and Spectrum CE Systems
  3. Molecular Diagnostics: Sale of diagnostic kits including OncoMate MSI Detection Kit for companion diagnostics in oncology
  4. Custom Manufacturing Services: Custom manufacturing capabilities including lyophilized PCR master mixes, mRNA manufacturing raw materials, and tailored R&D solutions
  5. Forensic DNA Analysis Products: Kits and instruments for forensic DNA analysis supporting law enforcement and forensic laboratories

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goWeb-based product catalog with account pricing
SubscriptionMonthlyEmail subscription with 20% discount incentive

Go-to-market motion2 records

Distribution channels5 records

Marketing channels9 records

Promega product offering

Product offering

Core offering

Promega Corporation develops and manufactures biological research reagents, assay kits, laboratory instruments, and molecular diagnostic products for life science research, drug discovery, forensic human identification, and clinical diagnostics. Its portfolio centers on proprietary NanoLuc luciferase-based bioluminescence platforms and includes nucleic acid extraction systems, PCR reagents, transfection reagents, plate readers, and companion diagnostic kits such as the OncoMate MSI Detection System.

Product overview

Promega Corporation is a life sciences reagent and instrument company offering a broad portfolio of bioluminescent technologies, assays, instruments, and molecular biology tools. The core technology platform centers on NanoLuc Luciferase and NanoBRET Target Engagement technology, which power products for drug discovery target engagement studies (NanoBRET TE K192 Kinase Selectivity System, TarSeer BRETSA System), cell biology assays, and protein analysis. The product portfolio includes: GoTaq Probe qPCR/RT-qPCR Systems for nucleic acid amplification; ReliaPrep RNA Miniprep and Maxwell RSC automated purification systems for sample preparation; GloMax Discover multimode plate readers and Quantus Fluorometer for detection; FuGENE HD transfection reagents for cellular delivery; QuantiFluor RNA Systems for quantitation; Water-Glo ATP testing for environmental monitoring; and forensic DNA analysis tools including OncoMate MSI Detection Kit and Spectrum CE Systems. Additional technology platforms include HaloTag protein labeling, HiBiT protein tagging, and Lumit bioluminescence immunoassays. The company offers custom manufacturing services including mRNA raw materials and assay development, distributed through global distribution agreements such as NimaGen IDseek MPS kits.

Differentiator

Problem solved

Functional benefit

Brands

  • GloMax: Line of microplate readers and luminometers for luminescence, fluorescence, and absorbance detection
  • GoTaq
  • NanoLuc
  • NanoBRET
  • Maxwell
  • ReliaPrep
  • QuantiFluor
  • FuGENE
  • HaloTag
  • Lumit

Products and services

  • NanoBRET TE K192 Kinase Selectivity System Live-cell assay system profiling compound cellular selectivity against 192 human kinases in a single experiment, providing quantitative occupancy data using an addition-only protocol.
  • GoTaq Probe qPCR and RT-qPCR Systems Ready-to-use 2X master mixes for quantitative PCR and RT-qPCR using hydrolysis probe detection, compatible with most real-time PCR instruments and resistant to PCR inhibitors.
  • ReliaPrep RNA Miniprep Systems Membrane-based RNA purification system for extracting high-quality total RNA from cultured cells and tissue samples with on-column DNase treatment, processing 100 cells to 5 million cells per prep.
  • GloMax Discover Microplate Reader Multimode microplate reader with luminescence, fluorescence, UV-visible absorbance, BRET and FRET detection capabilities for 6- to 384-well formats, optimized with Promega assay chemistries and SiLA2-compliant for lab automation integration.
  • FuGENE HD Transfection Reagent Non-liposomal transfection reagent for delivering nucleic acids into eukaryotic cells with high efficiency and low toxicity, compatible with serum-containing media and difficult-to-transfect cell lines.
  • QuantiFluor RNA System Fluorescent RNA-binding dye system for sensitive quantitation of small amounts of RNA, detecting as little as 100pg RNA with 0.1-500ng per microliter range.
  • QuantiFluor RNA Select System Add-and-read fluorescent RNA quantitation system with broad dynamic range (16-1000ng per microliter), ideal for RNA sequencing template inputs with ambient shipping compatibility.
  • Water-Glo System ATP bioluminescence-based microbial water testing kit providing low-level detection of all live microbes in minutes for industrial process, drinking water, wastewater, and environmental monitoring.
  • Maxwell RSC simplyRNA Blood Kit Automated RNA purification kit for extracting total RNA from 2.5ml fresh whole blood samples using Maxwell RSC Instruments with low elution volume.
  • pmirGLO Dual-Luciferase miRNA Target Expression Vector Reporter vector for quantitatively evaluating microRNA activity by inserting target sites downstream of firefly luciferase gene, with Renilla luciferase normalization.
  • Dual-Glo Luciferase Assay System Homogeneous reagent system for consecutive detection of firefly and Renilla luciferase activities in a single sample with 2-hour extended signal half-life, using an add-mix-measure protocol.
  • OncoMate MSI Detection Kit PCR-based microsatellite instability (MSI) detection assay for identifying MSI-High solid tumor patients as a companion diagnostic for KEYTRUDA immunotherapy.
  • TarSeer BRETSA Target Engagement System Live-cell target engagement platform that detects ligand-protein interactions in intact cells using bioluminescence resonance energy transfer-based shift assay technology, addressing the gap between biochemical and cellular assays for drug discovery.
  • Helix On-Site Stocking Service Onsite inventory management and stocking service providing convenient access to Promega products directly in laboratories.
  • mRNA Manufacturing Raw Materials Custom manufacturing services for mRNA therapeutics research including raw materials for LNP and mRNA delivery applications.

Quantifiable outcome

  • TarSeer BRETSA system applied to over 20 target classes
  • +1 more outcomes

Companies that use Promega

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles5 records

Promega technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature8 records

Promega partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor and core.

  • California State Polytechnic University, PomonaminorStrategic or Co-development Partner · 1 June 2026Promega contributed laboratory instrumentation to support Cal Poly's new Engineering Synthetic Cells course, combining coursework with research as a Course-based Undergraduate Research Experience (C.U.R.E.).
  • NimaGencoreChannel Partner/ Reseller/ Distributor · 1 April 2026Distribution agreement for NimaGen's IDseek massively parallel sequencing kit portfolio. Promega distributes more than 20 products across seven product families, including autosomal and Y-chromosomal STR profiling kits, microhaplotype analysis, and mitochondrial DNA sequencing kits through its global distribution network.
  • UBC RNA & Formulation CoreminorChannel Partner/ Reseller/ Distributor · 1 April 2026Authorization granted for UBC RNA & Formulation Core to distribute NanoLuc-Encoding mRNA for LNP and mRNA delivery research. Research supply arrangement supporting mRNA therapeutics research.
  • Merck & Co. (MSD)coreStrategic or Co-development Partner · 1 February 2026Collaboration supporting regulatory approval of Promega's OncoMate MSI Detection Kit as companion diagnostic for KEYTRUDA (pembrolizumab). Promega partnered with Merck for China's NMPA approval of the MSI-High diagnostic assay for solid tumor patients.
  • MilliporeSigma (Merck KGaA Life Science)coreStrategic or Co-development Partner · 1 October 2025Partnership to co-develop assay technologies capable of tracking cellular activity in real time within organoids. The collaboration aims to advance drug screening and discovery using 3D cell cultures, with plans to integrate Merck's Duolink with Promega's HiBiT technologies for enhanced cellular analysis.
  • Merck KGaA (MilliporeSigma)coreStrategic or Co-development Partner · 1 October 2025Strategic partnership announced in October to co-develop organoid drug screening assays. The collaboration leverages Promega's assay technologies with MilliporeSigma's organoid models for more physiologically relevant drug discovery platforms.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Promega competitors and assessment

Company assessment

Broad incumbents

  • Thermo Fisher Scientific: World's largest life sciences tools and diagnostics company, offering reagents, instruments, and molecular diagnostics. Directly comparable across Promega's portfolio, but at vastly greater scale and with broader catalog spanning everything from cell biology to clinical diagnostics.
  • Merck KGaA / MilliporeSigma: Life science tools division of Merck KGaA offering biochemicals, reagents, and instruments. Active Promega partner on organoid drug screening; broad catalog competes across many of Promega's product lines from a position of greater scale.
  • Agilent Technologies: Analytical instruments and life sciences tools company with comparable offerings in PCR/qPCR, nucleic acid analysis, and cell analysis. Broader portfolio spanning chromatography and mass spectrometry, with significantly larger revenue base than Promega.
  • Revvity (formerly PerkinElmer): Life sciences and diagnostics company with overlapping reagents, cell-based assays, and molecular diagnostics. Comparable in life sciences applications segment but operates broader analytical instruments portfolio.

Direct peers

  • Bio-Rad Laboratories: Public life sciences tools company with overlapping product lines in PCR/qPCR reagents (similar to GoTaq), digital PCR, protein analysis (Western blot), and clinical diagnostics. Closely comparable in scale, business model, and customer base to Promega.
  • Bio-Techne: Research reagents and diagnostics company with comparable portfolio in proteins, antibodies, ELISA/immunoassays (similar to Lumit), and cell/gene therapy workflow tools. Direct competitor in research reagents for drug discovery and academic markets.
  • QIAGEN: Molecular diagnostics and sample preparation specialist with overlapping products in nucleic acid extraction (similar to Maxwell), PCR, and companion diagnostics. Identified in the company data as a Promega competitor, with comparable scale and global footprint.
  • Abcam: Research reagent company specializing in antibodies and immunoassay tools, recently acquired by Danaher. Direct competitor in immunoassay reagents and protein detection — comparable to Promega's Lumit and HaloTag platforms for academic and pharma research customers.

Emerging players

  • GenScript: Biotechnology reagent and service company with comparable offerings in gene synthesis, protein production, and cell therapy reagents. Overlaps with Promega's nucleic acid and protein analysis tools, particularly for synthetic biology and cell/gene therapy customers.
  • Promocell: Specialty provider of primary cells, cell culture reagents, and cell-based assays with overlapping offerings in cell biology research. Comparable target customer base (academic and pharma researchers) but narrower product portfolio than Promega.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Promega social profiles

Digital presence

Promega compliance and trust

Trust signal

Compliance1 record

Promega financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Promega leadership team

Management profile

Number of profiles

Profiles2 records

Promega funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Promega M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Promega

What does Promega do?

Promega Corporation develops and manufactures biological research reagents, assay kits, laboratory instruments, and molecular diagnostic products for life science research, drug discovery, forensic human identification, and clinical diagnostics. Its portfolio centers on proprietary NanoLuc luciferase-based bioluminescence platforms and includes nucleic acid extraction systems, PCR reagents, transfection reagents, plate readers, and companion diagnostic kits such as the OncoMate MSI Detection System.

Is Promega a public or private company?

Promega is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Promega founded?

Promega was founded in 1978. It employs 1,001 to 5,000 people.

Where is Promega based?

Promega is headquartered in Madison, United States, in the North America region.

How does Promega make money?

Five revenue lines are on record. Research Reagents and Consumables are the primary driver. The others are laboratory Instruments, molecular Diagnostics, custom Manufacturing Services and forensic DNA Analysis Products.

Who are Promega's main competitors?

Broad incumbents on record are Thermo Fisher Scientific, Merck KGaA / MilliporeSigma, Agilent Technologies and Revvity (formerly PerkinElmer). Direct peers are Bio-Rad Laboratories, Bio-Techne, QIAGEN and Abcam. Emerging players are GenScript and Promocell.

Does Promega have an API?

No public API is recorded for Promega.

What industry is Promega in?

Promega's product category is Life Sciences Research Reagents and Instruments. Its primary akta.pro industry code is HLAAAIAI, Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation), with a secondary code of HLAGAIAB, Mass Spectrometry & Spectroscopy Instruments. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooGlobal Cell-Based Assays Market Report 2026-2030 | Secure Share in the $54.79 Billion Market Growing at 13.3% as Promega, Bio-Rad, PerkinElmer, and Danaher Scale AI AutomationThe global cell-based assays market is projected to grow from $29.41 billion in 2025 to $33.21 billion in 2026, then to $54.79 billion by 2030, a CAGR of 13.3%. Growth is driven by biologics sales, AI-assisted analysis, and laboratory automation, with North America as the largest region.NateJongkundang Health Promega, supporting heart disease patients campaign for 'World Heart Day': Nate NewsPromega, a Jongkundang Health subsidiary, launched a World Heart Day campaign to support heart disease patients. A donation event linked to omega-3 product purchases from the 14th to 27th will fund surgery costs for economically struggling patients, with proceeds going to the Korean Heart Foundation. The campaign aligns with the World Heart Federation's theme 'Don't Miss a Beat'.GenengnewsADCs, mAbs, CAR Ts: One Bioluminescent Platform Measures Them AllPromega's HiBiT Target Cell Killing platform measures cytotoxicity for CAR-T, ADCC, TDCC, and ADCP killing mechanisms. It uses bioluminescent target cells that release HiBiT upon death, generating a signal proportional to target cell death alone. The platform supports off-the-shelf cell lines and primary effector cells for high-throughput screening.BioSpacePromega Achieves 100% Renewable Electricity Across Global OperationsPromega released its 2026 Corporate Responsibility Report, announcing 100% renewable electricity across all global operations and completion of a value chain emissions inventory. The company validated near-term emissions reduction targets with the Science Based Targets initiative in April 2026. Scope 3 emissions represent about 76% of its total footprint.Med-Tech InsightsPromega tools used to power research into reduced breast cancer cell growthResearchers at Loughborough University are using Promega's 3D cell culture models and bioluminescence assays to study how exercise counteracts fat cells' cancer-promoting effects. Early findings show exercise reverses the viability increase caused by fat cells. The team is now investigating the molecular mechanisms behind this response.News-MedicalCountable Labs and Promega announce co-marketing agreement to facilitate end-to end biological sample preparation and rare variant detectionCountable Labs and Promega announced a co-marketing agreement to combine Promega's Maxwell nucleic acid extraction system with Countable PCR instruments for DNA and RNA quantification. The workflow achieved 0.08% minor allele frequency for KRAS G12C in cfDNA, and the companies will host a joint webinar on July 9, 2026.BioSpaceCountable Labs and Promega Announce Co-Marketing Agreement to Facilitate End-to End Biological Sample Preparation and Rare Variant DetectionCountable Labs and Promega announced a co-marketing agreement combining Promega's Maxwell nucleic acid extraction system with Countable PCR for DNA and RNA quantification. The workflow enables detection of rare variants, such as KRAS G12C at 0.08% MAF, and a joint webinar is scheduled for July 9, 2026.CalpolyCal Poly Partners with Innovative Scientists to Offer First Synthetic Cell CourseCal Poly has introduced a new upper-division course called Engineering Synthetic Cells that teaches undergraduates to build synthetic cells using cell-free protein expression systems, combining coursework with research as a Course-based Undergraduate Research Experience (C.U.R.E.). The course is supported by Schmidt Sciences funding and involves active partnerships with b.next (which provides the open-source Nucleus platform), Promega Corp (which contributed laboratory instrumentation), and Cephla (which provided a fluorescence microscope), alongside collaborations with several international universities including University College London, Imperial College London, and King's College London. Students are gaining hands-on experience with advanced lab equipment while conducting research on enzymes with potential applications in energy regeneration and biomedicine, contributing experimental data to a shared scientific commons.Business Wire BlogPromega Receives SBTi Validation for Near-Term Science-Based Emissions Reduction TargetsPromega received SBTi validation for its near-term emissions reduction targets, covering Scope 1, 2, and 3. The targets include a 47% cut in Scope 1 and 2 emissions and a 42% cut in Scope 3 by 2030, plus a supplier engagement commitment reaching 67% of suppliers by spend. Promega has already achieved 100% renewable electricity globally.EIN PresswireRestriction Enzymes Market Expected to Hit US$411.4 Mn by 2033 Amid Rising Demand | Persistence Market ResearchThe global restriction enzymes market is projected to grow from US$251.2 million in 2026 to US$411.4 million by 2033, a 7.3% CAGR. North America holds 40.8% of the market, while Asia Pacific is the fastest-growing region. Type II enzymes dominate with 41.6% share, driven by cloning and sequencing applications.